Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Mucin 1 - Pipeline Review, H2 2018 - ResearchAndMarkets.com

Research and Markets
Posted on: 19 Oct 18

The "Mucin 1 - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

This report outlays comprehensive information on the Mucin 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Mucin 1 targeted therapeutics development with respective active and dormant or discontinued projects.
Scope
  • The report provides a snapshot of the global therapeutic landscape for Mucin 1
  • The report reviews Mucin 1 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in Mucin 1 targeted therapeutics and enlists all their major and minor projects
  • The report assesses Mucin 1 targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews latest news and deals related to Mucin 1 targeted therapeutics

Companies Featured

  • Akshaya Bio Inc.
  • Bavarian Nordic A/S
  • Bioleaders Corp.
  • Boehringer Ingelheim GmbH
  • Etubics Corp.
  • GeoVax Labs Inc.
  • Merck KGaA
  • Minerva Biotechnologies Corp.
  • NantKwest Inc.
  • Peptron Inc.
  • Transgene SA
  • Vaxil Bio Therapeutics Ltd.

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/wncxng/mucin_1?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181018005431/en/

Business Wire
www.businesswire.com

Last updated on: 19/10/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.